Biotech Investors & VC Firms in Boston
86 firms in this list, with a median first check of $1M. 24 of them lead rounds. Generated from verified public data and updated continuously.
Eight Roads Ventures
MumbaiSeed–Late Stage$5M – $30M
33 people
Panacea Venture
SingaporeSeed–Late Stage
21 people
Four Cities
NewtonSeed–Series A
3 people
MVM Life Science Partners
LondonSeed–Late Stage$20M – $100M
20 people
Taihill Venture
CambridgePre-Seed–Seed
11 people
Quantonation
ParisPre-Seed–Series A
12 people
BIOSPRING PARTNERS
New YorkGrowth
22 people
Iaso Ventures
CambridgeSeed–Series A
15 people
APERTURE Venture Partners
New YorkSeed–Series C$1M – $5M
4 people
6 Dimensions Capital
Grand CaymanSeed–Late Stage
17 people
Fine Structures Ventures
CambridgePre-Seed–Late Stage
10 people
Luma Group
New YorkSeed–Growth
14 people
Curie.Bio
CambridgeSeed–Series A$5M – $15M
9 people
NYBC Ventures
New YorkSeed–Series B
8 people
Related lists
Investors & VC Firms in North America (13488)Investors & VC Firms in United States (12527)Investors & VC Firms in Europe (5831)Investors & VC Firms in Global (4707)AI & Machine Learning Investors & VC Firms (4538)Fintech Investors & VC Firms (4530)SaaS Investors & VC Firms (4205)Healthtech Investors & VC Firms (4177)Enterprise Software Investors & VC Firms (4092)Crypto & Web3 Investors & VC Firms (3961)
Data sourced from public filings and firms' own websites — see our methodology.

























































